ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,749.00
0.35%
S&P ASX All Technology
3,067.50
0.14%
Brent Oil
82.585
0.00%
US Dollar vs AUD
1.50761
-0.15%
Bitcoin
60,952.64
0.25%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. BioPlus Acquisition Corporation (BIOSU)

  7. BioPlus Acquisition Corporation (BIOSU) News

BIOSU

BioPlus Acquisition (BIOSU)

BioPlus Acquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIOSU
DateTimeSourceHeadlineSymbolCompany
17/10/202307:15Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:BIOSUBioPlus Acquisition Corporation
04/10/202322:39Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:BIOSUBioPlus Acquisition Corporation
04/10/202322:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOSUBioPlus Acquisition Corporation
04/10/202322:30GlobeNewswire Inc.BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to LiquidateNASDAQ:BIOSUBioPlus Acquisition Corporation
16/09/202306:00Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BIOSUBioPlus Acquisition Corporation
16/08/202323:01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BIOSUBioPlus Acquisition Corporation
15/08/202306:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIOSUBioPlus Acquisition Corporation
17/07/202322:01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:BIOSUBioPlus Acquisition Corporation
14/06/202320:09Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
14/06/202320:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSUBioPlus Acquisition Corporation
31/05/202306:04Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
20/05/202306:50Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
20/05/202306:05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
16/05/202306:29Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSUBioPlus Acquisition Corporation
15/05/202320:38Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:BIOSUBioPlus Acquisition Corporation
13/05/202306:17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BIOSUBioPlus Acquisition Corporation
03/05/202322:47Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSUBioPlus Acquisition Corporation
03/05/202322:44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSUBioPlus Acquisition Corporation
28/04/202306:35Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BIOSUBioPlus Acquisition Corporation
15/02/202307:39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSUBioPlus Acquisition Corporation
03/02/202302:10Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOSUBioPlus Acquisition Corporation
04/11/202208:10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSUBioPlus Acquisition Corporation
12/10/202207:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSUBioPlus Acquisition Corporation
11/08/202206:33Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSUBioPlus Acquisition Corporation
13/05/202206:55Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSUBioPlus Acquisition Corporation
12/03/202208:05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BIOSUBioPlus Acquisition Corporation
10/02/202206:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSUBioPlus Acquisition Corporation
07/12/202100:00GlobeNewswire Inc.BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public OfferingNASDAQ:BIOSUBioPlus Acquisition Corporation
03/12/202112:55GlobeNewswire Inc.BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public OfferingNASDAQ:BIOSUBioPlus Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:BIOSU

Your Recent History

ASX
XJO
S&P ASX 200
NASDAQ
MSFT
Microsoft
ASX
WES
Wesfarmers
NYSE
JPM
JP Morgan Chase
CCOM
SILVER
SILVER
COIN
ETHUSD
Ethereum
ASX
MQG
Macquarie
NYSE
MRK
Merck
NYSE
KO
Coca Cola
ASX
ORG
Origin Energy
ASX
XMM
S&P ASX 300 Metals and M...
NASDAQ
AAPL
Apple
ASX
XAO
Australian SE All Ordina...
NYSE
MCD
McDonalds
ASX
NAB
National Australia Bank
FX
EURAUD
Euro vs AUD
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved